- Home
- RANI vs CLSD Comparison
RANI vs CLSD Comparison
Compare RANI & CLSD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RANI
- CLSD
- Stock Information
- Founded
- RANI 2012
- CLSD 2011
- Country
- RANI United States
- CLSD United States
- Employees
- RANI N/A
- CLSD N/A
- Industry
- RANI Medicinal Chemicals and Botanical Products
- CLSD Biotechnology: Pharmaceutical Preparations
- Sector
- RANI Health Care
- CLSD Health Care
- Exchange
- RANI Nasdaq
- CLSD Nasdaq
- Market Cap
- RANI 24.2M
- CLSD 20.4M
- IPO Year
- RANI 2021
- CLSD 2016
- Fundamental
- Price
- RANI $1.90
- CLSD $3.49
- Analyst Decision
- RANI Strong Buy
- CLSD Hold
- Analyst Count
- RANI 6
- CLSD 4
- Target Price
- RANI $8.67
- CLSD $65.00
- AVG Volume (30 Days)
- RANI 21.6M
- CLSD 36.8K
- Earning Date
- RANI 11-06-2025
- CLSD 11-07-2025
- Dividend Yield
- RANI N/A
- CLSD N/A
- EPS Growth
- RANI N/A
- CLSD N/A
- EPS
- RANI N/A
- CLSD N/A
- Revenue
- RANI $1,200,000.00
- CLSD $3,329,000.00
- Revenue This Year
- RANI N/A
- CLSD $98.20
- Revenue Next Year
- RANI N/A
- CLSD $213.77
- P/E Ratio
- RANI N/A
- CLSD N/A
- Revenue Growth
- RANI N/A
- CLSD N/A
- 52 Week Low
- RANI $0.39
- CLSD $3.32
- 52 Week High
- RANI $3.87
- CLSD $17.10
- Technical
- Relative Strength Index (RSI)
- RANI 54.20
- CLSD 42.77
- Support Level
- RANI $1.77
- CLSD $3.60
- Resistance Level
- RANI $2.16
- CLSD $4.00
- Average True Range (ATR)
- RANI 0.35
- CLSD 0.33
- MACD
- RANI -0.07
- CLSD -0.08
- Stochastic Oscillator
- RANI 41.74
- CLSD 2.39
About RANI Rani Therapeutics Holdings Inc.
Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads in liquid form with high bioavailability.
About CLSD Clearside Biomedical Inc.
Clearside Biomedical Inc is a United States-based clinical biopharmaceutical company. It is engaged in developing pharmacological therapies to treat blinding disease of the eye through the suprachoroidal space, or SCS. The company's novel SCS injection platform, utilizing a proprietary SCS Microinjector, enables an in-office, repeatable, non-surgical procedure for the targeted and compartmentalized delivery of a wide variety of therapies to the macula, retina, or choroid to potentially preserve and improve vision in patients with sight-threatening eye diseases.